Systemic Therapy in Combination With Stereotactic Radiotherapy in Patients With Metastatic Colorectal Cancer up to 10 Metastatic Sites
Condition(s):Metastatic Colorectal Cancer; Oligometastatic DiseaseLast Updated:May 11, 2023Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Metastatic Colorectal Cancer; Oligometastatic DiseaseLast Updated:May 11, 2023Not yet recruiting
Condition(s):Lung Non-Small Cell Carcinoma; Stage IV Lung Cancer AJCC v8Last Updated:February 20, 2024Recruiting
Condition(s):Urothelial Cancer; Bladder Cancer; Genitourinary Cancer; Urogenital Neoplasms; Urogenital CancerLast Updated:February 28, 2024Recruiting
Condition(s):Centrally Located Hepatocellular Carcinoma; Stereotactic Body Radiotherapy; HepatectomyLast Updated:February 6, 2023Recruiting
Condition(s):Metastatic Non Small Cell Lung Cancer; Metastatic Bladder Cancer; Metastatic Renal Cell Carcinoma; Metastatic Head and Neck CancerLast Updated:October 17, 2023Recruiting
Condition(s):Prostate Cancer; Localized Malignant NeoplasmLast Updated:February 23, 2023Recruiting
Condition(s):Cervical Cancer; Cervical Cancer Recurrent; Cervical Cancer MetastaticLast Updated:March 21, 2024Recruiting
Condition(s):Cancer Of ProstateLast Updated:February 29, 2024Recruiting
Condition(s):Prostate CancerLast Updated:March 25, 2024Recruiting
Condition(s):Resectable Stage IIA to IIIB Non-small Cell Lung CancerLast Updated:February 15, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.